Client
Pharma company
Respondents
n=20 people
who recently started new medication
Used community to quickly identify early adopters for new injectable
Methods
Telephone interviews
Experience with new medication
Suggested Articles
Tracking the Diabetes Drugs Revolution
Patient, Endocrinologist, Primary Care Experiences and Expectations with GLP-1s and SGLT-2s
True trended insights, from both patients and HCPs, to bring clarity to your decision making
dQ&A Announces Research to be Presented at the European Association for the Study of Diabetes 2023 Annual Meeting
The company will present…
New Partnership Closes the Loop Between Clinical Data and Real-World Diabetes Experiences
dQ&A announces…
